<DOC>
	<DOCNO>NCT01738828</DOCNO>
	<brief_summary>The GLOBAL study international multi-center , prospective study design enroll 10,000 consecutive eligible subject clinically refer coronary CT angiography assessment suspect coronary artery disease ( CAD ) . The purpose study perform extensive biomarker analysis atherosclerosis patient phenotyped use advanced imaging modality atherosclerosis .</brief_summary>
	<brief_title>GLOBAL Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Ages 1890 2 . Caucasian NonHispanic NonLatino origin 3 . Referral coronary CT angiography evaluate presence CAD 4 . The patient sign appropriate Institutional Review Board approve Informed Consent Form 1 . Immunosuppressive immunomodulatory therapy include dose systemic corticosteroid precede 30 day ( except steroid administer premedication prior contrast administration CT scan within 24 hour ) . 2 . Chemotherapy precede year 3 . Major surgery precede 2 month 4 . Blood blood product transfusion precede 2 month 5 . Subjects coronary CT angiography contraindicate per institutional standard care 6 . Subjects previous coronary arterial revascularization ( PCI CABG ) 7 . Subjects atrial fibrillation/flutter frequent irregular rapid heart rhythm , occur within past 3 month 8 . Subjects pacemaker implantable cardioverterdefibrillator implant 9 . Active congestive heart failure presence know nonischemic cardiomyopathy 10 . Known genetic disorder atherosclerosis , lipid lipoprotein metabolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>